When the Referee Owns the Team — and Tennessee Changes the Rules
At the center of this issue is a simple question: should the entities responsible for managing prescription drug benefits also own the pharmacies that profit from those decisions?
Why Hospital Outpatient Isn’t the Default for Long-Term Infusion Anymore
The move toward infusion centers as the preferred site of care is not a short-term response. It aligns with broader industry trends, including specialty drug pipelines that continue to favor infused biologics and a sustained rise in infusion demand.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
A Playbook for Modern Ambulatory Infusion Care: How Providers Can Strengthen Experience, Outcomes, and Operational Performance
As specialty therapies expand and chronic conditions rise, infusion services must be viewed as both clinically intensive and deeply human.
The Hidden Autoimmune Disorder Affecting Our Kids: Understanding PANS and PANDAS
A delayed diagnosis can cause a progression in severity (from mild to moderate to severe), increased suffering for the entire family, as well as enhance the risk of long-term neurological damage and the time it takes for them to heal.
Patients Across the Country Deserve Better Access to Healthcare
By focusing on integrating care teams, expanding community programs, and addressing SDoH through policy reform, we can create a healthcare system that serves all patients — especially those most in need.
There is Still a Significant Need for Community Pharmacies
Losing these retail medication outlets creates more than just pharmacy deserts. In many low-income and underserved areas, drugstores also serve as grocery stores and hubs for essential services, and hence their closures mean communities lose crucial access points for a variety of goods and services.
Where Will AI Deployment Benefit Payers the Most?
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.
The Potential for AI in Drug Design
Despite misconceptions about its use, artificial intelligence (AI), through modalities such as machine learning models, is poised to enable companies to expedite the drug design process.
Rising Cost of New Medications, Will the People Who Need Them Most be able to Afford them?
Healthcare has traditionally been built around the convenience of the provider and not the patient. Worse, it tends to treat all patients the same regardless of the condition they are trying to manage. If we want to improve medication compliance, we have to make access, support, and most importantly financial assistance a priority.